IVF Clinic Caps Fees at $600 After Second Failed Cycle

When Ambika Bhaik watched a family member calculate whether getting pregnant might cost $12,000 or more, she realized the fertility industry had normalized financial panic as part of trying to have a baby.

Her solution launched in December 2023 and it's beautifully simple. Yellow IVF in Gurugram, India charges normal prices for the first two cycles, but if those fail, every attempt after that costs just $600, the clinic's cost price, no matter how many cycles it takes.

"From the third cycle onward, we walk the path with our patients," Bhaik says. "We share in the challenge rather than asking them to shoulder all the uncertainty alone."

The problem she's solving affects one in six couples globally. Male infertility accounts for 40% of cases, yet shame and silence mean couples often wait eight to ten years before seeking help, by which time age has narrowed their options dramatically.

Conventional IVF clinics optimize for the transaction, selling packages and individual cycles. Yellow IVF optimizes for what patients actually want: a baby.

Why This Inspires

The pricing structure isn't just generous, it's strategically aligned. The longer a patient struggles, the less money Yellow IVF makes from their case. That creates powerful incentive for the clinic to actually solve the problem rather than profit from repeated failures.

Bhaik acknowledges a competitor could copy the pricing tomorrow. "But the mindset behind it is much harder to replicate," she says.

That mindset shapes how the company grows too. Instead of owning every location, Yellow IVF partners with established local fertility doctors across India, bringing them systems and technology rather than competing. The network now includes about 20 centers from Kashmir to Kolkata, with recent partnerships in Bengaluru.

Bhaik refuses to rush expansion. "We'd rather grow slower with the right partners than faster with the wrong ones."

The company is building AI tools to help doctors with embryo selection and cycle planning, though they're not in clinical use yet. Plans include reaching 100 centers by 2030 and expanding across South Asia, the Middle East and Africa.

But Bhaik keeps returning to something smaller than revenue targets. "I hope Yellow becomes synonymous with trust," she says. "To make the fertility journey feel hopeful, not overwhelming."

In an industry that's trained patients to accept emotional and financial exhaustion as normal, one founder is proving there's another way.